1. Home
  2. VFF vs ATYR Comparison

VFF vs ATYR Comparison

Compare VFF & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Village Farms International Inc.

VFF

Village Farms International Inc.

HOLD

Current Price

$2.65

Market Cap

396.2M

Sector

N/A

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.80

Market Cap

83.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VFF
ATYR
Founded
1989
2005
Country
United States
United States
Employees
N/A
59
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.2M
83.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
VFF
ATYR
Price
$2.65
$0.80
Analyst Decision
Buy
Hold
Analyst Count
1
8
Target Price
N/A
$4.20
AVG Volume (30 Days)
1.2M
1.2M
Earning Date
03-12-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
184.38
N/A
EPS
0.27
N/A
Revenue
$215,937,000.00
N/A
Revenue This Year
$17.40
$9,628.95
Revenue Next Year
$17.10
$156.94
P/E Ratio
$10.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.64
52 Week High
$4.99
$7.29

Technical Indicators

Market Signals
Indicator
VFF
ATYR
Relative Strength Index (RSI) 30.78 41.07
Support Level $2.17 $0.67
Resistance Level $3.69 $0.85
Average True Range (ATR) 0.18 0.06
MACD -0.09 -0.02
Stochastic Oscillator 3.27 5.77

Price Performance

Historical Comparison
VFF
ATYR

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Leli . The company makes majority of its revenue from the Produce segment.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: